{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:24:54Z","timestamp":1790645094824,"version":"4.1.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s40266-020-00826-2","type":"journal-article","created":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T04:22:46Z","timestamp":1607919766000},"page":"181-192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Treatment of Seizures in Older Patients with Dementia"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9302-755X","authenticated-orcid":false,"given":"Benjamin","family":"Cretin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,14]]},"reference":[{"issue":"11","key":"826_CR1","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S1474-4422(09)70240-6","volume":"8","author":"MJ Brodie","year":"2009","unstructured":"Brodie MJ, Elder AT, Kwan P. Epilepsy in later life. Lancet Neurol. 2009;8(11):1019\u201330. https:\/\/doi.org\/10.1016\/S1474-4422(09)70240-6.","journal-title":"Lancet Neurol."},{"issue":"10225","key":"826_CR2","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0140-6736(19)33064-8","volume":"395","author":"A Sen","year":"2020","unstructured":"Sen A, Jette N, Husain M, Sander JW. Epilepsy in older people. Lancet. 2020;395(10225):735\u201348. https:\/\/doi.org\/10.1016\/S0140-6736(19)33064-8.","journal-title":"Lancet"},{"issue":"6","key":"826_CR3","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/ageing\/20.6.442","volume":"20","author":"R Tallis","year":"1991","unstructured":"Tallis R, Hall G, Craig I, Dean A. How common are epileptic seizures in old age? Age Ageing. 1991;20(6):442\u20138. https:\/\/doi.org\/10.1093\/ageing\/20.6.442.","journal-title":"Age Ageing."},{"issue":"1","key":"826_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1212\/WNL.0b013e318204a36a","volume":"76","author":"DC Hesdorffer","year":"2011","unstructured":"Hesdorffer DC, Logroscino G, Benn EK, Katri N, Cascino G, Hauser WA. Estimating risk for developing epilepsy: a population-based study in Rochester, Minnesota. Neurology. 2011;76(1):23\u20137. https:\/\/doi.org\/10.1212\/WNL.0b013e318204a36a.","journal-title":"Neurology"},{"issue":"10","key":"826_CR5","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S1474-4422(05)70172-1","volume":"4","author":"E Olafsson","year":"2005","unstructured":"Olafsson E, Ludvigsson P, Gudmundsson G, Hesdorffer D, Kjartansson O, Hauser WA. Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study. Lancet Neurol. 2005;4(10):627\u201334. https:\/\/doi.org\/10.1016\/S1474-4422(05)70172-1.","journal-title":"Lancet Neurol."},{"key":"826_CR6","doi-asserted-by":"publisher","unstructured":"GBD 2016 Epilepsy Collaborators. Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 [published correction appears in Lancet Neurol. 2019 May;18(5):e4].\u00a0Lancet Neurol. 2019;18(4):357\u201375. https:\/\/doi.org\/10.1016\/S1474-4422(18)30454-X.","DOI":"10.1016\/S1474-4422(18)30454-X"},{"key":"826_CR7","doi-asserted-by":"publisher","unstructured":"Faught E, Richman J, Martin R, et al. Incidence and prevalence of epilepsy among older U.S. Medicare beneficiaries. Neurology. 2012;78(7):448\u201353. https:\/\/doi.org\/10.1212\/WNL.0b013e3182477edc.","DOI":"10.1212\/WNL.0b013e3182477edc"},{"key":"826_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.eplepsyres.2017.11.022","volume":"139","author":"Q Ip","year":"2018","unstructured":"Ip Q, Malone DC, Chong J, Harris RB, Labiner DM. An update on the prevalence and incidence of epilepsy among older adults. Epilepsy Res. 2018;139:107\u201312. https:\/\/doi.org\/10.1016\/j.eplepsyres.2017.11.022.","journal-title":"Epilepsy Res."},{"issue":"3\u20134","key":"826_CR9","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000493484","volume":"51","author":"E Beghi","year":"2018","unstructured":"Beghi E, Giussani G. Aging and the epidemiology of epilepsy. Neuroepidemiology. 2018;51(3\u20134):216\u201323. https:\/\/doi.org\/10.1159\/000493484.","journal-title":"Neuroepidemiology."},{"key":"826_CR10","doi-asserted-by":"publisher","unstructured":"GBD 2016 Dementia Collaborators. Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.\u00a0Lancet Neurol. 2019;18(1):88\u2013106. https:\/\/doi.org\/10.1016\/S1474-4422(18)30403-4.","DOI":"10.1016\/S1474-4422(18)30403-4"},{"issue":"3","key":"826_CR11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1528-1157.1993.tb02586.x","volume":"34","author":"WA Hauser","year":"1993","unstructured":"Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935\u20131984. Epilepsia. 1993;34(3):453\u201368. https:\/\/doi.org\/10.1111\/j.1528-1157.1993.tb02586.x.","journal-title":"Epilepsia."},{"issue":"4","key":"826_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1755-5949.2011.00251.x","volume":"18","author":"D Friedman","year":"2012","unstructured":"Friedman D, Honig LS, Scarmeas N. Seizures and epilepsy in Alzheimer\u2019s disease. CNS Neurosci Ther. 2012;18(4):285\u201394. https:\/\/doi.org\/10.1111\/j.1755-5949.2011.00251.x.","journal-title":"CNS Neurosci Ther."},{"issue":"4","key":"826_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1600-0404.2010.01464.x","volume":"124","author":"H Stefan","year":"2011","unstructured":"Stefan H. Epilepsy in the elderly: facts and challenges. Acta Neurol Scand. 2011;124(4):223\u20137. https:\/\/doi.org\/10.1111\/j.1600-0404.2010.01464.x.","journal-title":"Acta Neurol Scand."},{"issue":"6","key":"826_CR14","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/epi.13744","volume":"58","author":"A Subota","year":"2017","unstructured":"Subota A, Pham T, Jett\u00e9 N, Sauro K, Lorenzetti D, Holroyd-Leduc J. The association between dementia and epilepsy: a systematic review and meta-analysis. Epilepsia. 2017;58(6):962\u201372. https:\/\/doi.org\/10.1111\/epi.13744.","journal-title":"Epilepsia."},{"issue":"1","key":"826_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1176\/appi.neuropsych.15060143","volume":"28","author":"RA Sarkis","year":"2016","unstructured":"Sarkis RA, Dickerson BC, Cole AJ, Chemali ZN. Clinical and neurophysiologic characteristics of unprovoked seizures in patients diagnosed with dementia. J Neuropsychiatry Clin Neurosci. 2016;28(1):56\u201361. https:\/\/doi.org\/10.1176\/appi.neuropsych.15060143.","journal-title":"J Neuropsychiatry Clin Neurosci."},{"key":"826_CR16","doi-asserted-by":"publisher","unstructured":"Dementia: not all about Alzheimer\u2019s.\u00a0Lancet. 2015;386(10004):1600. https:\/\/doi.org\/10.1016\/S0140-6736(15)00672-8.","DOI":"10.1016\/S0140-6736(15)00672-8"},{"issue":"3","key":"826_CR17","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1212\/wnl.46.3.727","volume":"46","author":"DC Hesdorffer","year":"1996","unstructured":"Hesdorffer DC, Hauser WA, Annegers JF, Kokmen E, Rocca WA. Dementia and adult-onset unprovoked seizures. Neurology. 1996;46(3):727\u201330. https:\/\/doi.org\/10.1212\/wnl.46.3.727.","journal-title":"Neurology."},{"issue":"1","key":"826_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3233\/JAD-170031","volume":"60","author":"AJ Beagle","year":"2017","unstructured":"Beagle AJ, Darwish SM, Ranasinghe KG, La AL, Karageorgiou E, Vossel KA. Relative incidence of seizures and myoclonus in Alzheimer\u2019s disease, dementia with Lewy bodies, and frontotemporal dementia. J Alzheimers Dis. 2017;60(1):211\u201323. https:\/\/doi.org\/10.3233\/JAD-170031.","journal-title":"J Alzheimers Dis."},{"issue":"1","key":"826_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.yebeh.2008.08.012","volume":"14","author":"SC Rao","year":"2009","unstructured":"Rao SC, Dove G, Cascino GD, Petersen RC. Recurrent seizures in patients with dementia: frequency, seizure types, and treatment outcome. Epilepsy Behav. 2009;14(1):118\u201320. https:\/\/doi.org\/10.1016\/j.yebeh.2008.08.012.","journal-title":"Epilepsy Behav."},{"issue":"3","key":"826_CR20","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.eplepsyres.2012.08.002","volume":"102","author":"B Cretin","year":"2012","unstructured":"Cretin B, Blanc F, Gaultier C, Sellal F. Epileptic amnesic syndrome revealing Alzheimer\u2019s disease. Epilepsy Res. 2012;102(3):206\u20139. https:\/\/doi.org\/10.1016\/j.eplepsyres.2012.08.002.","journal-title":"Epilepsy Res."},{"issue":"9","key":"826_CR21","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1001\/jamaneurol.2013.136","volume":"70","author":"KA Vossel","year":"2013","unstructured":"Vossel KA, Beagle AJ, Rabinovici GD, et al. Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol. 2013;70(9):1158\u201366. https:\/\/doi.org\/10.1001\/jamaneurol.2013.136.","journal-title":"JAMA Neurol."},{"issue":"2","key":"826_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000093664","volume":"22","author":"DA Lozsadi","year":"2006","unstructured":"Lozsadi DA, Larner AJ. Prevalence and causes of seizures at the time of diagnosis of probable Alzheimer\u2019s disease. Dement Geriatr Cogn Disord. 2006;22(2):121\u20134. https:\/\/doi.org\/10.1159\/000093664.","journal-title":"Dement Geriatr Cogn Disord."},{"issue":"3","key":"826_CR23","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3233\/JAD-150096","volume":"52","author":"B Cretin","year":"2016","unstructured":"Cretin B, Sellal F, Philippi N, et al. Epileptic prodromal Alzheimer\u2019s disease, a retrospective study of 13 new cases: expanding the spectrum of Alzheimer\u2019s disease to an epileptic variant? J Alzheimers Dis. 2016;52(3):1125\u201333. https:\/\/doi.org\/10.3233\/JAD-150096.","journal-title":"J Alzheimers Dis."},{"issue":"3","key":"826_CR24","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3233\/JAD-191315","volume":"74","author":"D Arnaldi","year":"2020","unstructured":"Arnaldi D, Donniaquio A, Mattioli P, et al. Epilepsy in neurodegenerative dementias: a clinical, epidemiological, and EEG study. J Alzheimers Dis. 2020;74(3):865\u201374. https:\/\/doi.org\/10.3233\/JAD-191315.","journal-title":"J Alzheimers Dis."},{"issue":"4","key":"826_CR25","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3233\/JAD-170392","volume":"60","author":"JC DiFrancesco","year":"2017","unstructured":"DiFrancesco JC, Tremolizzo L, Polonia V, et al. Adult-onset epilepsy in presymptomatic Alzheimer\u2019s disease: a retrospective study. J Alzheimers Dis. 2017;60(4):1267\u201374. https:\/\/doi.org\/10.3233\/JAD-170392.","journal-title":"J Alzheimers Dis."},{"key":"826_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neurobiolaging.2018.09.006","volume":"73","author":"C Costa","year":"2019","unstructured":"Costa C, Romoli M, Liguori C, et al. Alzheimer\u2019s disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology. Neurobiol Aging. 2019;73:61\u20137. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.09.006.","journal-title":"Neurobiol Aging."},{"issue":"9","key":"826_CR27","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1212\/wnl.36.9.1226","volume":"36","author":"WA Hauser","year":"1986","unstructured":"Hauser WA, Morris ML, Heston LL, Anderson VE. Seizures and myoclonus in patients with Alzheimer\u2019s disease. Neurology. 1986;36(9):1226\u201330. https:\/\/doi.org\/10.1212\/wnl.36.9.1226.","journal-title":"Neurology."},{"key":"826_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.yebeh.2014.04.015","volume":"36","author":"D Sherzai","year":"2014","unstructured":"Sherzai D, Losey T, Vega S, Sherzai A. Seizures and dementia in the elderly: nationwide inpatient sample 1999\u20132008. Epilepsy Behav. 2014;36:53\u20136. https:\/\/doi.org\/10.1016\/j.yebeh.2014.04.015.","journal-title":"Epilepsy Behav."},{"issue":"1","key":"826_CR29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/ene.14043","volume":"27","author":"J Zelano","year":"2020","unstructured":"Zelano J, Brigo F, Garcia-Patek S. Increased risk of epilepsy in patients registered in the Swedish Dementia Registry. Eur J Neurol. 2020;27(1):129\u201335. https:\/\/doi.org\/10.1111\/ene.14043.","journal-title":"Eur J Neurol."},{"key":"826_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.seizure.2019.06.016","volume":"71","author":"J Baker","year":"2019","unstructured":"Baker J, Libretto T, Henley W, Zeman A. The prevalence and clinical features of epileptic seizures in a memory clinic population. Seizure. 2019;71:83\u201392. https:\/\/doi.org\/10.1016\/j.seizure.2019.06.016.","journal-title":"Seizure."},{"issue":"6","key":"826_CR31","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.neurol.2017.03.028","volume":"173","author":"B Cretin","year":"2017","unstructured":"Cretin B, Philippi N, Bousiges O, et al. Do we know how to diagnose epilepsy early in Alzheimer\u2019s disease? Rev Neurol (Paris). 2017;173(6):374\u201380. https:\/\/doi.org\/10.1016\/j.neurol.2017.03.028.","journal-title":"Rev Neurol (Paris)."},{"key":"826_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09937-7.2020","author":"J V\u00f6glein","year":"2020","unstructured":"V\u00f6glein J, Ricard I, Noachtar S, et al. Seizures in Alzheimer\u2019s disease are highly recurrent and associated with a poor disease course. J Neurol. 2020. https:\/\/doi.org\/10.1007\/s00415-020-09937-7.2020(Epub 2 Jun 2020).","journal-title":"J Neurol."},{"issue":"4","key":"826_CR33","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/epi.12045","volume":"54","author":"P Imfeld","year":"2013","unstructured":"Imfeld P, Bodmer M, Schuerch M, Jick SS, Meier CR. Seizures in patients with Alzheimer\u2019s disease or vascular dementia: a population-based nested case-control analysis. Epilepsia. 2013;54(4):700\u20137. https:\/\/doi.org\/10.1111\/epi.12045.","journal-title":"Epilepsia."},{"key":"826_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eplepsyres.2014.10.012","volume":"109","author":"S Gasparini","year":"2015","unstructured":"Gasparini S, Ferlazzo E, Beghi E, et al. Epilepsy associated with Leukoaraiosis mainly affects temporal lobe: a casual or causal relationship? Epilepsy Res. 2015;109:1\u20138. https:\/\/doi.org\/10.1016\/j.eplepsyres.2014.10.012.","journal-title":"Epilepsy Res."},{"issue":"9","key":"826_CR35","doi-asserted-by":"publisher","first-page":"e988","DOI":"10.1212\/WNL.0000000000007010","volume":"92","author":"EL Johnson","year":"2019","unstructured":"Johnson EL, Krauss GL, Lee AK, et al. Association between white matter hyperintensities, cortical volumes, and late-onset epilepsy. Neurology. 2019;92(9):e988\u201395. https:\/\/doi.org\/10.1212\/WNL.0000000000007010.","journal-title":"Neurology."},{"issue":"9","key":"826_CR36","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1212\/WNL.0000000000003662","volume":"88","author":"H Choi","year":"2017","unstructured":"Choi H, Pack A, Elkind MS, Longstreth WT Jr, Ton TG, Onchiri F. Predictors of incident epilepsy in older adults: the Cardiovascular Health Study. Neurology. 2017;88(9):870\u20137. https:\/\/doi.org\/10.1212\/WNL.0000000000003662.","journal-title":"Neurology."},{"issue":"1","key":"826_CR37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1684\/pnv.2017.0652","volume":"15","author":"B Cretin","year":"2017","unstructured":"Cretin B, Philippi N, Dibitonto L, Blanc F. Epilepsy at the prodromal stages of neurodegenerative diseases. Geriatr Psychol Neuropsychiatr Vieil. 2017;15(1):75\u201382. https:\/\/doi.org\/10.1684\/pnv.2017.0652.","journal-title":"Geriatr Psychol Neuropsychiatr Vieil."},{"issue":"6","key":"826_CR38","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/psyg.12434","volume":"19","author":"K Ukai","year":"2019","unstructured":"Ukai K, Watanabe M. Transient epileptic amnesia accompanied by prodromal symptoms of dementia with Lewy bodies: the second case report in the literature. Psychogeriatrics. 2019;19(6):622\u20133. https:\/\/doi.org\/10.1111\/psyg.12434.","journal-title":"Psychogeriatrics."},{"key":"826_CR39","doi-asserted-by":"publisher","first-page":"107311","DOI":"10.1016\/j.yebeh.2020.107311","volume":"111","author":"R Marawar","year":"2020","unstructured":"Marawar R, Wakim N, Albin RL, Dodge H. Seizure occurrence and related mortality in dementia with Lewy bodies. Epilepsy Behav. 2020;111:107311. https:\/\/doi.org\/10.1016\/j.yebeh.2020.107311(Epub 18 Jul 2020).","journal-title":"Epilepsy Behav."},{"issue":"11","key":"826_CR40","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/acn3.257","volume":"2","author":"M Morris","year":"2015","unstructured":"Morris M, Sanchez PE, Verret L, et al. Network dysfunction in \u03b1-synuclein transgenic mice and human Lewy body dementia. Ann Clin Transl Neurol. 2015;2(11):1012\u201328. https:\/\/doi.org\/10.1002\/acn3.257.","journal-title":"Ann Clin Transl Neurol."},{"issue":"10004","key":"826_CR41","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S0140-6736(15)00461-4","volume":"386","author":"J Bang","year":"2015","unstructured":"Bang J, Spina S, Miller BL. Frontotemporal dementia. Lancet. 2015;386(10004):1672\u201382. https:\/\/doi.org\/10.1016\/S0140-6736(15)00461-4.","journal-title":"Lancet"},{"issue":"4","key":"826_CR42","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/j.1528-1167.2009.02285.x","volume":"51","author":"E Beghi","year":"2010","unstructured":"Beghi E, Carpio A, Forsgren L, et al. Recommendation for a definition of acute symptomatic seizure. Epilepsia. 2010;51(4):671\u20135. https:\/\/doi.org\/10.1111\/j.1528-1167.2009.02285.x.","journal-title":"Epilepsia."},{"issue":"1","key":"826_CR43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1684\/pnv.2007.0096","volume":"5","author":"C Gaxatte","year":"2007","unstructured":"Gaxatte C, Puisieux F, Derambure P. Does the epileptic threshold change with age? Psychol Neuropsychiatr Vieil. 2007;5(1):5\u20139. https:\/\/doi.org\/10.1684\/pnv.2007.0096.","journal-title":"Psychol Neuropsychiatr Vieil."},{"issue":"8","key":"826_CR44","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1001\/archneur.1990.00530080029006","volume":"47","author":"MF Romanelli","year":"1990","unstructured":"Romanelli MF, Morris JC, Ashkin K, Coben LA. Advanced Alzheimer\u2019s disease is a risk factor for late-onset seizures. Arch Neurol. 1990;47(8):847\u201350. https:\/\/doi.org\/10.1001\/archneur.1990.00530080029006.","journal-title":"Arch Neurol."},{"issue":"4","key":"826_CR45","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1177\/089198879400700407","volume":"7","author":"MF Mendez","year":"1994","unstructured":"Mendez MF, Catanzaro P, Doss RC, Arguello R, Frey WH 2nd. Seizures in Alzheimer\u2019s disease: clinicopathologic study. J Geriatr Psychiatry Neurol. 1994;7(4):230\u20133. https:\/\/doi.org\/10.1177\/089198879400700407.","journal-title":"J Geriatr Psychiatry Neurol."},{"key":"826_CR46","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.brainresbull.2020.04.009","volume":"160","author":"FS Giorgi","year":"2020","unstructured":"Giorgi FS, Saccaro LF, Busceti CL, Biagioni F, Fornai F. Epilepsy and Alzheimer\u2019s disease: potential mechanisms for an association. Brain Res Bull. 2020;160:107\u201320. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.04.009.","journal-title":"Brain Res Bull."},{"issue":"4","key":"826_CR47","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1001\/archneurol.2009.15","volume":"66","author":"JJ Palop","year":"2009","unstructured":"Palop JJ, Mucke L. Epilepsy and cognitive impairments in Alzheimer disease. Arch Neurol. 2009;66(4):435\u201340. https:\/\/doi.org\/10.1001\/archneurol.2009.15.","journal-title":"Arch Neurol."},{"issue":"4","key":"826_CR48","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne VL, Burnham S, Bourgeat P, et al. Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol. 2013;12(4):357\u201367. https:\/\/doi.org\/10.1016\/S1474-4422(13)70044-9.","journal-title":"Lancet Neurol."},{"issue":"6","key":"826_CR49","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nm.4330","volume":"23","author":"AD Lam","year":"2017","unstructured":"Lam AD, Deck G, Goldman A, Eskandar EN, Noebels J, Cole AJ. Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer\u2019s disease. Nat Med. 2017;23(6):678\u201380. https:\/\/doi.org\/10.1038\/nm.4330.","journal-title":"Nat Med."},{"issue":"6","key":"826_CR50","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/ana.24794","volume":"80","author":"KA Vossel","year":"2016","unstructured":"Vossel KA, Ranasinghe KG, Beagle AJ, et al. Incidence and impact of subclinical epileptiform activity in Alzheimer\u2019s disease. Ann Neurol. 2016;80(6):858\u201370. https:\/\/doi.org\/10.1002\/ana.24794.","journal-title":"Ann Neurol."},{"issue":"2","key":"826_CR51","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1523\/JNEUROSCI.4152-10.2011","volume":"31","author":"ED Roberson","year":"2011","unstructured":"Roberson ED, Halabisky B, Yoo JW, et al. Amyloid-\u03b2\/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer\u2019s disease. J Neurosci. 2011;31(2):700\u201311. https:\/\/doi.org\/10.1523\/JNEUROSCI.4152-10.2011.","journal-title":"J Neurosci."},{"issue":"42","key":"826_CR52","doi-asserted-by":"publisher","first-page":"E2895","DOI":"10.1073\/pnas.1121081109","volume":"109","author":"PE Sanchez","year":"2012","unstructured":"Sanchez PE, Zhu L, Verret L, et al. Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer\u2019s disease model. Proc Natl Acad Sci USA. 2012;109(42):E2895\u2013903. https:\/\/doi.org\/10.1073\/pnas.1121081109.","journal-title":"Proc Natl Acad Sci USA"},{"key":"826_CR53","doi-asserted-by":"publisher","unstructured":"Noebels J. A perfect storm: converging paths of epilepsy and Alzheimer\u2019s dementia intersect in the hippocampal formation.\u00a0Epilepsia. 2011;52 Suppl. 1(Suppl. 1):39\u201346. https:\/\/doi.org\/10.1111\/j.1528-1167.2010.02909.x.","DOI":"10.1111\/j.1528-1167.2010.02909.x"},{"issue":"10","key":"826_CR54","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.3390\/ijms21103676","volume":"21","author":"R Lin","year":"2020","unstructured":"Lin R, Jones NC, Kwan P. Unravelling the role of glycogen synthase kinase-3 in Alzheimer\u2019s disease-related epileptic seizures. Int J Mol Sci. 2020;21(10):3676. https:\/\/doi.org\/10.3390\/ijms21103676.","journal-title":"Int J Mol Sci."},{"issue":"12","key":"826_CR55","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nrn.2016.141","volume":"17","author":"JJ Palop","year":"2016","unstructured":"Palop JJ, Mucke L. Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat Rev Neurosci. 2016;17(12):777\u201392. https:\/\/doi.org\/10.1038\/nrn.2016.141.","journal-title":"Nat Rev Neurosci."},{"key":"826_CR56","doi-asserted-by":"publisher","unstructured":"Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging [published correction appears in Lancet Neurol. 2013;12(6):532].\u00a0Lancet Neurol. 2013;12(5):483\u201397. https:\/\/doi.org\/10.1016\/S1474-4422(13)70060-7.","DOI":"10.1016\/S1474-4422(13)70060-7"},{"issue":"3","key":"826_CR57","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nrneurol.2015.10","volume":"11","author":"ND Prins","year":"2015","unstructured":"Prins ND, Scheltens P. White matter hyperintensities, cognitive impairment and dementia: an update. Nat Rev Neurol. 2015;11(3):157\u201365. https:\/\/doi.org\/10.1038\/nrneurol.2015.10.","journal-title":"Nat Rev Neurol."},{"issue":"Pt 2","key":"826_CR58","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/brain\/awl317","volume":"130","author":"S Ivens","year":"2007","unstructured":"Ivens S, Kaufer D, Flores LP, et al. TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain. 2007;130(Pt 2):535\u201347. https:\/\/doi.org\/10.1093\/brain\/awl317.","journal-title":"Brain"},{"key":"826_CR59","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.expneurol.2011.09.033","volume":"244","author":"A Vezzani","year":"2013","unstructured":"Vezzani A, Aronica E, Mazarati A, Pittman QJ. Epilepsy and brain inflammation. Exp Neurol. 2013;244:11\u201321. https:\/\/doi.org\/10.1016\/j.expneurol.2011.09.033.","journal-title":"Exp Neurol."},{"issue":"1\u20132","key":"826_CR60","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jns.2007.06.004","volume":"263","author":"J De Reuck","year":"2007","unstructured":"De Reuck J, Nagy E, Van Maele G. Seizures and epilepsy in patients with lacunar strokes. J Neurol Sci. 2007;263(1\u20132):75\u20138. https:\/\/doi.org\/10.1016\/j.jns.2007.06.004.","journal-title":"J Neurol Sci."},{"issue":"9","key":"826_CR61","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/S1474-4422(16)30029-1","volume":"15","author":"Z Arvanitakis","year":"2016","unstructured":"Arvanitakis Z, Capuano AW, Leurgans SE, Bennett DA, Schneider JA. Relation of cerebral vessel disease to Alzheimer\u2019s disease dementia and cognitive function in elderly people: a cross-sectional study. Lancet Neurol. 2016;15(9):934\u201343. https:\/\/doi.org\/10.1016\/S1474-4422(16)30029-1.","journal-title":"Lancet Neurol."},{"key":"826_CR62","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3389\/fnagi.2018.00190","volume":"10","author":"JJ van der Zande","year":"2018","unstructured":"van der Zande JJ, Gouw AA, van Steenoven I, Scheltens P, Stam CJ, Lemstra AW. EEG characteristics of dementia with Lewy bodies, Alzheimer\u2019s disease and mixed pathology. Front Aging Neurosci. 2018;10:190. https:\/\/doi.org\/10.3389\/fnagi.2018.00190.","journal-title":"Front Aging Neurosci."},{"key":"826_CR63","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.nbd.2013.06.005","volume":"58","author":"AM Garc\u00eda-Cabrero","year":"2013","unstructured":"Garc\u00eda-Cabrero AM, Guerrero-L\u00f3pez R, Gir\u00e1ldez BG, et al. Hyperexcitability and epileptic seizures in a model of frontotemporal dementia. Neurobiol Dis. 2013;58:200\u20138. https:\/\/doi.org\/10.1016\/j.nbd.2013.06.005.","journal-title":"Neurobiol Dis."},{"issue":"6","key":"826_CR64","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/WNR.0000000000001425","volume":"31","author":"M Kuroda","year":"2020","unstructured":"Kuroda M, Matsuwaki T, Tanaka Y, Yamanouchi K, Nishihara M. Convulsive responses to seizure-inducible drugs are exacerbated in progranulin-deficient mice. NeuroReport. 2020;31(6):478\u201383. https:\/\/doi.org\/10.1097\/WNR.0000000000001425.","journal-title":"NeuroReport"},{"issue":"Pt 12","key":"826_CR65","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1093\/brain\/aww250","volume":"139","author":"SC Vatsavayai","year":"2016","unstructured":"Vatsavayai SC, Yoon SJ, Gardner RC, et al. Timing and significance of pathological features in C9orf72 expansion-associated frontotemporal dementia. Brain. 2016;139(Pt 12):3202\u201316. https:\/\/doi.org\/10.1093\/brain\/aww250.","journal-title":"Brain"},{"issue":"2","key":"826_CR66","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00401-017-1709-7","volume":"134","author":"TL Spires-Jones","year":"2017","unstructured":"Spires-Jones TL, Attems J, Thal DR. Interactions of pathological proteins in neurodegenerative diseases. Acta Neuropathol. 2017;134(2):187\u2013205. https:\/\/doi.org\/10.1007\/s00401-017-1709-7.","journal-title":"Acta Neuropathol."},{"key":"826_CR67","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.eplepsyres.2018.03.005","volume":"142","author":"P Desmarais","year":"2018","unstructured":"Desmarais P, Miville C, Mil\u00e1n-Tom\u00e1s \u00c1, et al. Age representation in antiepileptic drug trials: a systematic review and meta-analysis. Epilepsy Res. 2018;142:9\u201315. https:\/\/doi.org\/10.1016\/j.eplepsyres.2018.03.005.","journal-title":"Epilepsy Res."},{"issue":"7","key":"826_CR68","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1111\/epi.16068","volume":"60","author":"N Lezaic","year":"2019","unstructured":"Lezaic N, Gore G, Josephson CB, Wiebe S, Jett\u00e9 N, Keezer MR. The medical treatment of epilepsy in the elderly: a systematic review and meta-analysis. Epilepsia. 2019;60(7):1325\u201340. https:\/\/doi.org\/10.1111\/epi.16068.","journal-title":"Epilepsia."},{"issue":"11","key":"826_CR69","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1111\/epi.16366","volume":"60","author":"S Lattanzi","year":"2019","unstructured":"Lattanzi S, Trinka E, Del Giovane C, Nardone R, Silvestrini M, Brigo F. Antiepileptic drug monotherapy for epilepsy in the elderly: a systematic review and network meta-analysis. Epilepsia. 2019;60(11):2245\u201354. https:\/\/doi.org\/10.1111\/epi.16366.","journal-title":"Epilepsia."},{"issue":"4","key":"826_CR70","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.yebeh.2010.01.015","volume":"17","author":"E Cumbo","year":"2010","unstructured":"Cumbo E, Ligori LD. Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer\u2019s disease. Epilepsy Behav. 2010;17(4):461\u20136. https:\/\/doi.org\/10.1016\/j.yebeh.2010.01.015.","journal-title":"Epilepsy Behav."},{"issue":"11","key":"826_CR71","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1080\/14656566.2018.1496237","volume":"19","author":"B Cretin","year":"2018","unstructured":"Cretin B. Pharmacotherapeutic strategies for treating epilepsy in patients with Alzheimer\u2019s disease. Expert Opin Pharmacother. 2018;19(11):1201\u20139. https:\/\/doi.org\/10.1080\/14656566.2018.1496237.","journal-title":"Expert Opin Pharmacother."},{"issue":"3","key":"826_CR72","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/ane.12920","volume":"138","author":"V Villanueva","year":"2018","unstructured":"Villanueva V, Gir\u00e1ldez BG, Toledo M, De Haan GJ, Cumbo E, Gambardella A, et al. Lacosamide monotherapy in clinical practice: a retrospective chart review. Acta Neurol Scand. 2018;138(3):186\u201394. https:\/\/doi.org\/10.1111\/ane.12920.","journal-title":"Acta Neurol Scand."},{"issue":"42","key":"826_CR73","doi-asserted-by":"publisher","first-page":"E2895","DOI":"10.1073\/pnas.1121081109","volume":"109","author":"PE Sanchez","year":"2012","unstructured":"Sanchez PE, Zhu L, Verret L, Vossel KA, Orr AG, Cirrito JR, et al. Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer\u2019s disease model. Proc Natl Acad Sci USA. 2012;109(42):E2895\u2013903. https:\/\/doi.org\/10.1073\/pnas.1121081109.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"826_CR74","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.neuron.2012.03.023","volume":"74","author":"A Bakker","year":"2012","unstructured":"Bakker A, Krauss GL, Albert MS, Speck CL, Jones LR, Stark CE, et al. Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron. 2012;74(3):467\u201374. https:\/\/doi.org\/10.1016\/j.neuron.2012.03.023.","journal-title":"Neuron"},{"key":"826_CR75","doi-asserted-by":"publisher","first-page":"106404","DOI":"10.1016\/j.eplepsyres.2020.106404","volume":"166","author":"S Arnold","year":"2020","unstructured":"Arnold S, Laloyaux C, Schulz AL, Elmoufti S, Yates S, Fakhoury T. Long-term safety and efficacy of brivaracetam in adults with focal seizures: results from an open-label, multinational, follow-up trial. Epilepsy Res. 2020;166:106404. https:\/\/doi.org\/10.1016\/j.eplepsyres.2020.106404.","journal-title":"Epilepsy Res."},{"issue":"1","key":"826_CR76","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13195-015-0110-9","volume":"7","author":"HB Nygaard","year":"2015","unstructured":"Nygaard HB, Kaufman AC, Sekine-Konno T, Huh LL, Going H, Feldman SJ, et al. Brivaracetam, but not ethosuximide, reverses memory impairments in an Alzheimer\u2019s disease mouse model. Alzheimers Res Ther. 2015;7(1):25. https:\/\/doi.org\/10.1186\/s13195-015-0110-9.","journal-title":"Alzheimers Res Ther."},{"issue":"8","key":"826_CR77","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/epi.13448","volume":"57","author":"E Ferlazzo","year":"2016","unstructured":"Ferlazzo E, Gasparini S, Beghi E, et al. Epilepsy in cerebrovascular diseases: review of experimental and clinical data with meta-analysis of risk factors. Epilepsia. 2016;57(8):1205\u201314. https:\/\/doi.org\/10.1111\/epi.13448.","journal-title":"Epilepsia."},{"key":"826_CR78","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.seizure.2018.08.001","volume":"61","author":"F Brigo","year":"2018","unstructured":"Brigo F, Lattanzi S, Zelano J, et al. Randomized controlled trials of antiepileptic drugs for the treatment of post-stroke seizures: a systematic review with network meta-analysis. Seizure. 2018;61:57\u201362. https:\/\/doi.org\/10.1016\/j.seizure.2018.08.001.","journal-title":"Seizure."},{"issue":"12","key":"826_CR79","doi-asserted-by":"publisher","first-page":"CD011922","DOI":"10.1002\/14651858.CD011922.pub3","volume":"12","author":"J Liu","year":"2018","unstructured":"Liu J, Wang LN, Wu LY, Wang YP. Treatment of epilepsy for people with Alzheimer\u2019s disease. Cochrane Database Syst Rev. 2018;12(12):CD011922. https:\/\/doi.org\/10.1002\/14651858.CD011922.pub3.","journal-title":"Cochrane Database Syst Rev."},{"issue":"4","key":"826_CR80","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1080\/14656566.2019.1707185","volume":"21","author":"B Cretin","year":"2020","unstructured":"Cretin B, Blanc F. How does epilepsy impact the pharmacotherapeutic management of patients with dementia with Lewy bodies? Expert Opin Pharmacother. 2020;21(4):377\u20139. https:\/\/doi.org\/10.1080\/14656566.2019.1707185.","journal-title":"Expert Opin Pharmacother."},{"key":"826_CR81","doi-asserted-by":"publisher","first-page":"106724","DOI":"10.1016\/j.yebeh.2019.106724","volume":"102","author":"N Lezaic","year":"2020","unstructured":"Lezaic N, Roussy J, Masson H, Jett\u00e9 N, Keezer MR. Epilepsy in the elderly: unique challenges in an increasingly prevalent population. Epilepsy Behav. 2020;102:106724. https:\/\/doi.org\/10.1016\/j.yebeh.2019.106724.","journal-title":"Epilepsy Behav."},{"issue":"10","key":"826_CR82","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1111\/bcp.13653","volume":"84","author":"LC Vu","year":"2018","unstructured":"Vu LC, Piccenna L, Kwan P, O\u2019Brien TJ. New-onset epilepsy in the elderly. Br J Clin Pharmacol. 2018;84(10):2208\u201317. https:\/\/doi.org\/10.1111\/bcp.13653.","journal-title":"Br J Clin Pharmacol."},{"issue":"7","key":"826_CR83","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/epi.16069","volume":"60","author":"RT Wechsler","year":"2019","unstructured":"Wechsler RT, Radtke RA, Smith M, et al. Serum sodium levels and related treatment-emergent adverse events during eslicarbazepine acetate use in adults with epilepsy. Epilepsia. 2019;60(7):1341\u201352. https:\/\/doi.org\/10.1111\/epi.16069.","journal-title":"Epilepsia."},{"key":"826_CR84","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04573-5","author":"M Safahani","year":"2020","unstructured":"Safahani M, Aligholi H, Asadi-Pooya AA. Management of antiepileptic drug-induced nutrition-related adverse effects. Neurol Sci. 2020. https:\/\/doi.org\/10.1007\/s10072-020-04573-5(Epub 14 Jul 2020).","journal-title":"Neurol Sci."},{"key":"826_CR85","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.yebeh.2019.05.038","volume":"97","author":"G Zaccara","year":"2019","unstructured":"Zaccara G, Lattanzi S. Comorbidity between epilepsy and cardiac arrhythmias: implication for treatment. Epilepsy Behav. 2019;97:304\u201312. https:\/\/doi.org\/10.1016\/j.yebeh.2019.05.038.","journal-title":"Epilepsy Behav."},{"key":"826_CR86","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2020.1806236","author":"R Roberti","year":"2020","unstructured":"Roberti R, Palleria C, Nesci V, et al. Pharmacokinetic considerations about antiseizure medications in the elderly. Expert Opin Drug Metab Toxicol. 2020. https:\/\/doi.org\/10.1080\/17425255.2020.1806236(Epub 6 Aug 2020).","journal-title":"Expert Opin Drug Metab Toxicol."}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-020-00826-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-020-00826-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-020-00826-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T04:24:47Z","timestamp":1614486287000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-020-00826-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,14]]},"references-count":86,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["826"],"URL":"https:\/\/doi.org\/10.1007\/s40266-020-00826-2","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,14]]},"assertion":[{"value":"18 November 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received for the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Benjamin Cretin reports fees and honorarium from UCB-Pharma, Eisai-Pharma, and Advicenne-Pharma.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"BC designed and conceptualized study, analyzed the data, drafted the manuscript for intellectual content, and read and approved the final version of the manuscript.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}